SOMOS

Lack of data in the medical industry is critical and life-threatening to the Latino population. Latinos represent +20% of the US population, +650M people worldwide or 1/10 of the world's population and +23bn usd in sales for the pharma industry just in the US and still, most drugs haven't been proved to be effective on Latinos. The reason is that <1.2% of genetic data available for research comes from these populations; and we only represent <1%in clinical trials. There have been zero drugs discovered through Latino genetic information. 
Through the most accurate genetic LATINO ANCESTRY service, we create critical mass and create bio panels in collaboration with Indigenous communities to understand the correlation between unique genetic variants and diseases.

To crowdsource the GENOME of LATINOS, we aim to generate millions of datasets. To achieve this goal, we've developed the best-resolution ancestry service for Latinos to gain critical mass.

SOMOS provides specific high ethnic resolution to Latino/Hispanic/Native American customers, improving on commercially available services like 23&me and Ancestry.
For the first time, Latino users can identify their Mayan, Nahua, and Huichol ancestry, among 11 other regions and ethnic groups within the continent.

Our platform does and will do:

- gather the largest Latino community sharing decentralized genetic data
- help identify new genetic markers and associations to diseases
- identify new potential clinical trial participants for SOMOS and other research partners
- Partner with Latino brands to collect more data and improve engagement
- update new LATINO traits using unique Latino genetic variants available

There are +650M people who identify as Latino across the globe. Just within the US, Latinos represent up to 18.5% of the total population, or 62M+ people. Mexican Americans rank as the largest Hispanic subgroup in the US (62% of Hispanic population or 38M+)
Health disparities linked to minorities just in the US will cost up to 50bn usd by 2035. SOMOS is addressing a public health challenge

We have been creating an incentive model to co-participate with indigenous communities. Actually we decided too implement web3.0 solutions like blockchain to allow full ownership and data governance to the participants because we identified an unethical data management in Mexico.
We walk the talk, we have visited tens of indigenous communities to understand their needs before even participating in our project. We decided to create in the short future an ancestral consortium where community leaders will help us take smart decision on how to use the funds for the execution of our community projects.
A percentage of the profits that collective data generates, will directly go to projects within indigenous community, ie.: free STEAM education and scholarships for young students.

We met 13 year ago in Med School, have worked together in Mi ADN (first company incorporated in Mexico by Federico). Have turned a long and lasting friendship into a shared passion. We received two grants by the Mexican Government to do genetic research in indigenous communities; 
2019 winners of Masschallenge-Accelhub Bridge to Boston,2020 winners of LatinX Fest,2021 Voces de la comunidad Latina in the US.

We are passionate for technology in Medicine as a powerful tool to help exponentially.

We have built a group of professionals, researchers, advisors,ambassadors and teammates with unique experience in health, understanding of the Latino communities from the social, scientific and commercial perspectives

We need more exposure and access to:
- alliances with biotech and health industry leaders
- collaborations with researchers and institutions
- access to capital
- access to grants and philanthropic resources
- reach, exposure, PR and social proof

SOMOS is a community dependant, mission driven solution that generates social impact within a community level. Being of part of MIT Solve will help us create strategic alliances and identify potential partners to scale faster prioritizing return on society before return on investment. We are a voice for the underepresented communities and partnerships are the best way to create sustainable impact

SOMOS: THE MOST COMPLETE DNA PLATFORM FOR LATINOS

Historically, the diversity represented through different populations DNA for genomic research has been overwhelmingly biased which creates gaps in knowledge about the genomes from people in the rest of the world thus delaying Precision Medicine development . At SOMOS we work dilligently to enhance Latin American diversity inclusion and representation in genomic research.
SOMOS is the First Descentralized Pan American Biobank to Unlock Precision Medicine Solutions through the understanding of Latino Genetic Information  At SOMOS we are rewriting reality by mapping the latino genome to enable precision health solutions for our future generations. We are creating the largest decentralized Pan American Biobank (in history) to unlock Latino Precision Medicine, Without owning any sample! ;Instead we are empowering participants that join to own their data and have always the consensus and freedom to decide to participate.

SOMOS core vision is based on 3 critical and unique pillars: 1.- Data decentralization (all the data collected is owned & governed by each participant through blockchain technology) 2.- Latino driven (Somos partners with indigenous communities & leaders for dynamic decision making) 3.- Social remuneration (incentive alignment for participants) Latinos use traditional medicine tools that have been developed through caucasian scientific databases. We are the first company focusing on aggregating Native American data to improve the genetic services and enable precision medicine for Latinos.

SOMOS is creating an ecosystem based on data integration to understand better how genomics will improve precision health and wellness of our Latino people and nations

Next Year:

- More than 50,000 Latino users in the SOMOS platforms via existing sales and partnership channels 

- 7 new indigenous communities added to the pipeline and 700 samples in total; This means short, medium and long term incentives and relationships with communities to address their needs and including them in our Collaborative Science Model

- Implementation and integration of 3 new genomic reports for Latinos (wellbeing, nutrition, fitness) 

- First NFTs (Non fungible tokens) marketplace for Native American Indigenous artists-artisans - Win 3 Retail distribution partnerships in the Latino Market 

- Establishing collaborations with private and public healthcare institutions for massive data collection

Next 5 Years:  -Worlds First Decentralized Panamerican Biobank: +500 Indigenous Communities represented for the first time in genomic databases and clinical trials

- We will become the first and largest Pan American Organization for Dynamic and Democratized Digital Health

Integrated by 2 pilars: 1. Pan American Latam Biohub Consortium for Biotech & Bio banking  Democratization and Decentralization 2. Ancestral Assembly for Recognition & Reward and self  determination of the Indigenous Nations 

Creating the First Digital Collaborative Economy Ecosystem for Science & Technology Self Sustainability

1.a.2 Proportion of total government spending on essential services (education, health and social protection)

3.4 By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all 3.d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks

We calculate the impact by number of users, number associations between genetic data and diseases and partnerships to identify new associations.

Precision Medicine can’t be translated into practice for minorities.  The reason: lack of representation in scientific databases The real problem lies in data generation, who is generating genetic and health data from underrepresented groups and how is that data being generated and treated? We have asked our selves this question for years and committed many mistakes during the process The answer: lack of trust in science and lack of will to implement technology for the masses and for good Decentralizing data builds trust with indigenous communities (we have personally visited a dozen of indigenous communities and discussed this issue), and this mirrors the Latino community concerns about data sharing and safety

A scalable metadata approach needs to build a responsible, transparent, traceable and honest framework for data sharing and science generation

Reasons Why Traditional DNA companies don’t take into consideration our Latin America Nations and Communities…

It requires Purpose and Passion

Mainly because increasing the representation of diverse participants in genomics research requires investing time, energy and resources intentionally to develop trust and create long sustainable relationships between communities and researchers to ensure that genomics research is both equitable and inclusive.

Cultural and Legal Complexities

It involves creating bridges beyond language, geography, colors and ideas to create consensus. For the last 5 years we have been traveling and connecting Indigenous Nations throughout the continent to amplify their voices within digital ecosystems.

Glass Ceilling in Emerging Countries

Capital & Investments for Science and Tech Development tend to follow regional support within developed nations; Traditional DNA companies and their Governments invest in their own communities and networks creating a glass barrier for precision medicine advancement in underrepresented populations

Centralization, Consensus and Privacy 

Centralization of resources by Institutions in emerging countries has created "Data hoarders” (DinosauruScientists as we call them ) that slow the pace of innovation;

We are using ancestral knowledge to create impactful solutions and strategies for data sharing. We have successfully implemented blockchain to create BIO NFTs that allow each participant to gain access, governance and control over their genetic data, this way, we can offer incentives or share profits with users who's data has generated pool or collaborative value.
Our proprietary algorithms improve as we add more Latino and Indigenous participants to the network and biobank.
Our model of ancestral consortium helps us make consented decisions on data usage and profit distribution

We are all about diversity. We understand the needs of Latin America as all of our team are Latinos based in Latin America and some of our advisors are from Indigenous background. Part of our short term incentive plan in our collaborative science model within the communities is to enable connectivity and STEM/Web 3.0 Education to teach fishing skills for the Digital economy.  We know that education is the way for sustainable change!

1.SAAS: State of the Art highest resolution Latino DNA Ancestry service and Health actionable insights. 98,000,000 USD considering 10% of the total addressable Latino genetic ancestry testing Market according to MIT projections. Subscription upsells: 49,000,000 USD with a 50% yearly churn rate 2.DAAS: (data as a service): Licensing of IP for Pharma companies. Our unique Latino biobank is highly needed for successful drug development and validation. Contracts range from 60-400 musd depending on the approach 3. Moonshot: genetic target identification and drug development tailored for Latinos and Native Americans. Example of one highly prevalent disease in Latinos (NASH): market size equals 22.5 bn usd, and no drug has been developed yet.

Our Direct to Consumer services are our key to sustainability in the short term. At this moment we are profitable, self sustainable with zero debt. Our medium term growth financial strategy includes monetization through data access for the pharma industry.  SOMOS is democratizing the Genomics industry by decentralizing data, empowering users with consensus and transparency:

received +400k in 2 grants by the Mexican government to collect data and develop algorithms
+5000 active-paid users through organic reach,  we are creating a recurrent revenue model with genetic insights and traits (health, wellness & more)
+225k USD in revenue during last year
-We have only received 100k ticket from Angel Investor
- Launched in top crowdfunding platform
-We have received proposals for the full seed round but differ the offer to include commmunity through crowdfunding.